Adaptimmune Therapeutics PLC (ADAP)
1.12
+0.11
(+10.89%)
USD |
NASDAQ |
Apr 23, 16:00
1.15
+0.03
(+2.68%)
After-Hours: 20:00
Adaptimmune Therapeutics Price: 1.12 for April 23, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Apr 23, 2024 | 1.04 | 1.16 | 1.00 | 1.12 | 1.119M |
| Apr 22, 2024 | 0.99 | 1.08 | 0.94 | 1.01 | 694255.0 |
| Apr 19, 2024 | 0.9201 | 1.10 | 0.92 | 0.9767 | 1.482M |
| Apr 18, 2024 | 0.9676 | 0.9893 | 0.8721 | 0.8984 | 3.346M |
| Apr 17, 2024 | 1.02 | 1.045 | 0.9301 | 0.987 | 1.222M |
| Apr 16, 2024 | 1.05 | 1.06 | 0.9801 | 1.03 | 1.224M |
| Apr 15, 2024 | 1.20 | 1.21 | 1.05 | 1.05 | 1.324M |
| Apr 12, 2024 | 1.20 | 1.280 | 1.13 | 1.16 | 3.079M |
| Apr 11, 2024 | 1.28 | 1.34 | 1.26 | 1.29 | 882268.0 |
| Apr 10, 2024 | 1.33 | 1.33 | 1.25 | 1.27 | 1.515M |
| Apr 09, 2024 | 1.36 | 1.405 | 1.35 | 1.37 | 718236.0 |
| Apr 08, 2024 | 1.40 | 1.41 | 1.33 | 1.36 | 1.025M |
| Apr 05, 2024 | 1.39 | 1.42 | 1.32 | 1.37 | 1.205M |
| Apr 04, 2024 | 1.41 | 1.45 | 1.35 | 1.35 | 777369.0 |
| Apr 03, 2024 | 1.40 | 1.42 | 1.35 | 1.38 | 1.636M |
| Apr 02, 2024 | 1.46 | 1.46 | 1.36 | 1.40 | 1.148M |
| Apr 01, 2024 | 1.55 | 1.55 | 1.45 | 1.47 | 1.334M |
| Mar 28, 2024 | 1.65 | 1.65 | 1.53 | 1.58 | 1.068M |
| Mar 27, 2024 | 1.55 | 1.625 | 1.47 | 1.58 | 1.184M |
| Mar 26, 2024 | 1.45 | 1.57 | 1.38 | 1.52 | 1.195M |
| Mar 25, 2024 | 1.46 | 1.56 | 1.42 | 1.44 | 1.176M |
| Mar 22, 2024 | 1.34 | 1.49 | 1.324 | 1.44 | 1.672M |
| Mar 21, 2024 | 1.29 | 1.40 | 1.29 | 1.34 | 1.148M |
| Mar 20, 2024 | 1.44 | 1.44 | 1.24 | 1.33 | 3.079M |
| Mar 19, 2024 | 1.45 | 1.52 | 1.38 | 1.41 | 1.179M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
0.429
Minimum
Nov 20 2023
12.10
Maximum
Jun 02 2020
3.170
Average
2.23
Median
Apr 04 2022
Price Benchmarks
| Biodexa Pharmaceuticals Plc | 0.8081 |
| NuCana PLC | 4.00 |
| Autolus Therapeutics PLC | 4.48 |
| Mereo BioPharma Group PLC | 2.78 |
| TC BioPharm (Holdings) PLC | 1.58 |
Price Related Metrics
| PS Ratio | 3.740 |
| Price to Book Value | 6.996 |
| Earnings Yield | -42.30% |
| Market Cap | 276.44M |